Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE)
Published . Updated .
This report is about pharma and health.
Directly affected
- ABBV AbbVie+11.4% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- PFE Pfizer+8.9% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
- MRK Merck+3.2% 18d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
| XLV | -3.03% | -2.77% | base | after close | after close | after close | after close |
| XBI | -3.49% | +0.99% | base | after close | after close | after close | after close |
| LLY | -9.71% | -8.92% | base | after close | after close | after close | after close |
| JNJ | -2.53% | -0.72% | base | after close | after close | after close | after close |
| PFE | -2.33% | -3.34% | base | after close | after close | after close | after close |
| MRK | -5.94% | -5.65% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE) Seeking Alpha
Source: Seeking Alpha
Select Sector Spdr Tr (XLV) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | three days earlier | -0.72% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -2.53% | final price |
| Eli Lilly (LLY) | three days earlier | -8.92% | final price |
| Eli Lilly (LLY) | five days earlier | -9.71% | final price |
| Merck (MRK) | three days earlier | -5.65% | final price |
| Merck (MRK) | five days earlier | -5.94% | final price |
| Pfizer (PFE) | three days earlier | -3.34% | final price |
| Pfizer (PFE) | five days earlier | -2.33% | final price |
| Spdr Series Trust (XBI) | three days earlier | +0.99% | final price |
| Spdr Series Trust (XBI) | five days earlier | -3.49% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -2.77% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -3.03% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 47 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 36 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 53 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 71 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 37 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 73 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies carried with this story
- XLV Select Sector Spdr Tr
In “Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
- XBI Spdr Series Trust
For “Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE),” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
- LLY Eli Lilly
Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 31 Oct 2026 story “Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE).” Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
- JNJ Johnson & Johnson
In “Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
- PFE Pfizer
For “Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE),” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
- MRK Merck
Merck (MRK) is linked, with no stored direction, medium confidence in the 31 Oct 2026 story “Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE).” Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “healthcare” (pharma and health) in this story
Select Sector Spdr Tr (XLV)
Select Sector Spdr Tr (XLV) is the company in “Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE),” the 31 Oct 2026 this story story.
Select Sector Spdr Tr (XLV) is on the page because Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
Also listed, Spdr Series Trust (XBI): SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “healthcare” (pharma and health) in this story
Dates and price levels for Select Sector Spdr Tr (XLV)
LLY traded between 1131.55 and 1447.86 across 20 sessions. The latest close on file is 1415.62.
What the saved facts support for Select Sector Spdr Tr (XLV)
46 out of 100
“Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growth (ABBV:NYSE)” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.